EA200000987A1 - Алифатические аминокарбоновые и аминосульфоновые кислоты, аминонитрилы и аминотетразолы как агенты сохранения клеток - Google Patents
Алифатические аминокарбоновые и аминосульфоновые кислоты, аминонитрилы и аминотетразолы как агенты сохранения клетокInfo
- Publication number
- EA200000987A1 EA200000987A1 EA200000987A EA200000987A EA200000987A1 EA 200000987 A1 EA200000987 A1 EA 200000987A1 EA 200000987 A EA200000987 A EA 200000987A EA 200000987 A EA200000987 A EA 200000987A EA 200000987 A1 EA200000987 A1 EA 200000987A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- agents
- carbon atoms
- aminothetrazoles
- aminocarbonic
- aminonitriles
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- YMRIDJQAEZFTSC-UHFFFAOYSA-N 2,3-dihydro-1h-tetrazole Chemical compound N1NC=NN1 YMRIDJQAEZFTSC-UHFFFAOYSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- -1 phosphonate ester Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/25—Aminoacetonitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Dental Preparations (AREA)
- Materials For Medical Uses (AREA)
Abstract
Описаны новые соединения формулы (I), в которых R= (CH)CH, где m равно 0 или целому числу в диапазоне от 1 до 16, или Rпредставляет собой алкенил, алкинил, алкокси, алкилтио или алкилсульфинильную группу, имеющую от 2 до 17 атомов углерода; R= H, CHили CHCH; R= H или CH; R= H или CH; Rпредставляет собой низший алкил, имеющий от 1 до 5 атомов углерода; n равно целому числу в диапазоне от 1 до 3, и X представляет собой карбоксил (COOH) или карбалкокси (COOR), циано (C≡N), фосфоновую кислоту (POH), фосфонатный сложный эфир (PO[R]) или 5-тетразол; или их фармацевтически приемлемые соли. Данные соединения предпочтительно являются оптически чистыми энантиомерами R- или S-конфигурации, в которых R=R=R=H, R=CHи Rпредставляет собой насыщенную алифатическую цепь, содержащую от одного до пяти атомов углерода. Эти соединения полезны в качестве агентов сохранения клеток.Отчет о международном поиске был опубликован 2000.01.20
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7948998P | 1998-03-26 | 1998-03-26 | |
US7948898P | 1998-03-26 | 1998-03-26 | |
PCT/CA1999/000250 WO1999048858A2 (en) | 1998-03-26 | 1999-03-25 | Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200000987A1 true EA200000987A1 (ru) | 2001-06-25 |
EA003677B1 EA003677B1 (ru) | 2003-08-28 |
Family
ID=26762066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000987A EA003677B1 (ru) | 1998-03-26 | 1999-03-25 | Алифатические аминокарбоновые и аминосульфоновые кислоты, аминонитрилы и аминотетразолы как агенты сохранения клеток |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1064254B1 (ru) |
JP (1) | JP2002507591A (ru) |
CN (1) | CN1213999C (ru) |
AT (1) | ATE375975T1 (ru) |
AU (1) | AU767098B2 (ru) |
BR (1) | BR9909103A (ru) |
CA (1) | CA2325943A1 (ru) |
DE (1) | DE69937340T2 (ru) |
EA (1) | EA003677B1 (ru) |
ES (1) | ES2296383T3 (ru) |
NO (1) | NO20004774L (ru) |
PL (1) | PL343531A1 (ru) |
SK (1) | SK16662000A3 (ru) |
TR (1) | TR200002756T2 (ru) |
WO (1) | WO1999048858A2 (ru) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3113026A (en) * | 1959-01-19 | 1963-12-03 | Gen Aniline & Film Corp | Polyvinyl alcohol photographic silver halide emulsions |
DE1567221A1 (de) * | 1965-06-01 | 1970-04-16 | Berlin Chemie Veb | Systemische Fungizide |
BE758165A (fr) * | 1969-10-28 | 1971-04-28 | Cilag Chemie | Adamantylurees et procedes pour les preparer |
IL45563A0 (en) * | 1973-09-05 | 1974-11-29 | Sumitomo Chemical Co | N-substituted aminonitrile derivatives,their preparation and their use as fungicides |
US3991208A (en) * | 1973-12-28 | 1976-11-09 | Millmaster Onyx Corporation | Amphoteric surface-active agents |
DE2555769C3 (de) * | 1975-12-11 | 1980-01-03 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von an der Aminogruppe aliphatisch substituierten Glycinnitrilen |
DE3010599A1 (de) * | 1979-03-22 | 1980-10-09 | Continental Pharma | Derivate von glycinamid, deren herstellung und verwendung |
US4548726A (en) * | 1984-11-16 | 1985-10-22 | Texaco Inc. | Water base hydraulic fluid |
KR930005009B1 (ko) * | 1990-03-27 | 1993-06-11 | 한국과학기술연구원 | N-알킬치환아미노메틸포스폰산 유도체의 제조방법 |
US5169868A (en) * | 1991-03-01 | 1992-12-08 | University Of Saskatchewan | Aliphatic propargylamines as specific mao-b inhibitors |
JPH0856655A (ja) * | 1994-08-16 | 1996-03-05 | Frontier:Kk | 細胞致死剤および細胞死抑制剤 |
CA2619901A1 (en) * | 1996-05-31 | 1997-12-04 | Allelix Neuroscience Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
-
1999
- 1999-03-25 PL PL99343531A patent/PL343531A1/xx not_active Application Discontinuation
- 1999-03-25 TR TR2000/02756T patent/TR200002756T2/xx unknown
- 1999-03-25 EA EA200000987A patent/EA003677B1/ru not_active IP Right Cessation
- 1999-03-25 ES ES99908728T patent/ES2296383T3/es not_active Expired - Lifetime
- 1999-03-25 JP JP2000537843A patent/JP2002507591A/ja active Pending
- 1999-03-25 SK SK1666-2000A patent/SK16662000A3/sk unknown
- 1999-03-25 DE DE69937340T patent/DE69937340T2/de not_active Expired - Fee Related
- 1999-03-25 AT AT99908728T patent/ATE375975T1/de not_active IP Right Cessation
- 1999-03-25 WO PCT/CA1999/000250 patent/WO1999048858A2/en active IP Right Grant
- 1999-03-25 BR BR9909103-8A patent/BR9909103A/pt not_active IP Right Cessation
- 1999-03-25 CA CA002325943A patent/CA2325943A1/en not_active Abandoned
- 1999-03-25 EP EP99908728A patent/EP1064254B1/en not_active Expired - Lifetime
- 1999-03-25 AU AU28240/99A patent/AU767098B2/en not_active Ceased
- 1999-03-25 CN CNB998056383A patent/CN1213999C/zh not_active Expired - Fee Related
-
2000
- 2000-09-25 NO NO20004774A patent/NO20004774L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE375975T1 (de) | 2007-11-15 |
CN1213999C (zh) | 2005-08-10 |
EA003677B1 (ru) | 2003-08-28 |
AU2824099A (en) | 1999-10-18 |
CN1299342A (zh) | 2001-06-13 |
NO20004774D0 (no) | 2000-09-25 |
DE69937340T2 (de) | 2008-07-17 |
WO1999048858A2 (en) | 1999-09-30 |
NO20004774L (no) | 2000-09-25 |
PL343531A1 (en) | 2001-08-27 |
CA2325943A1 (en) | 1999-09-30 |
ES2296383T3 (es) | 2008-04-16 |
TR200002756T2 (tr) | 2000-12-21 |
WO1999048858A3 (en) | 2000-01-20 |
JP2002507591A (ja) | 2002-03-12 |
EP1064254A2 (en) | 2001-01-03 |
AU767098B2 (en) | 2003-10-30 |
EP1064254B1 (en) | 2007-10-17 |
SK16662000A3 (sk) | 2001-05-10 |
DE69937340D1 (de) | 2007-11-29 |
BR9909103A (pt) | 2001-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE262506T1 (de) | Quarternäre fettsäure-triethanolamin-estersalze und ihre verwendung als weichmacher von geweben | |
ATE253581T1 (de) | Verfahren zur herstellung von 3,4- alkylendioxythiophen-2,5-dicarbonsäurederivaten | |
DE69929877D1 (de) | BENZOCHINONDERIVATE ENTHALTENDE HEMMER VON NF-kB | |
DE69730727D1 (de) | Neue verwendung von 1,3-propanediol derivaten | |
FI945426A0 (fi) | GABA- ja L-glutamiinihappoanalogit kohtauksenvastaiseen käsittelyyn | |
CO5200791A1 (es) | Acidos 3-propil gamma-aminobutiricos mono- y disustituidos | |
TW343975B (en) | New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents | |
DE3372364D1 (en) | 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives | |
EA200000987A1 (ru) | Алифатические аминокарбоновые и аминосульфоновые кислоты, аминонитрилы и аминотетразолы как агенты сохранения клеток | |
DE69116922D1 (de) | Triazinderivatsalze mit Oxasäuren des Phosphors | |
ATE140001T1 (de) | Isochromanderivate | |
FI845102A0 (fi) | Imidazo/1,2-c/pyrimidiner. | |
KR920701216A (ko) | 관절염 치료제로서의 제미날 비스포스폰산 및 유도체 | |
KR870005985A (ko) | 구아니디노벤조 에스테르유도체 및 그의 제조방법 | |
ES2036572T3 (es) | Procedimiento de preparacion de acidos 2-arilpropionicos. | |
DE69110107D1 (de) | Verfahren zur Herstellung von 3-Alkoxymethyl Cephalosporinderivate. | |
FR2795727B1 (fr) | Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique | |
DK391087A (da) | Bicyclooctanderivater | |
KR870007188A (ko) | 경구 활성 포스포닐히드록시아실 프롤린 및 그의 제조 방법 | |
ATE243696T1 (de) | C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren | |
IT1268414B1 (it) | Enantiomeri farmacologicamente attivi | |
MX9302970A (es) | Analogos de acido l-glutamico y gaba para tratamiento anti-ataque. | |
TW349949B (en) | New imidazole derivatives, preparation process, intermediates obtained, use as medicaments, pharmaceutical compositions and new use | |
ES2188464T3 (es) | Procedimiento para la obtencion de esteres de n-acil-aminoacidos y n-acil-aminoacetales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |